Citation

Suad Kapetanovic, Lisa Aaron, Grace Montepiedra, Patricia Sirois, James M. Oleske, Kathleen Malee, Deborah Pearson, Sharon L. Nichols, Patricia A. Garvie, John J. Farley, Molly Nozyce, Mark Mintz, Paige L. Williams. The use of second generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV. AIDS Patient Care and STDs. 2009. 23: 939-47. PMID: 19827949

Citation

Carol Onyango, Danstan Bagenda, Anthony Mwatha, S. Omer, Philippa Musoke, Francis Mmiro, Sheryl L. Zwerski, Brenda Asiimwe-Kateera, Maria Musisi, Mary Glenn Fowler, Laura A. Guay, Brooks Jackson. Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: findings from two perinatal HIV prevention trials in Kampala, Uganda. Journal of Acquired Immune Deficiency Syndromes. 2009. EPub Ahead of Print. PMID: 19779355

Citation

Myron Levin, Jeffrey Anderson, George Seage, Paige L. Williams. Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.. Journal of Acquired Immune Deficiency Syndromes. 2009. 50: 182-91. PMID: 19131890

Citation

Diane V. Havlir, Richard H. Haubrich, Sharon A. Riddler, Greg DiRienzo, Lauren Komarow, William G. Powderly, Karin L. Klingman, Kevin W. Garren, Tania George, James F. Rooney, Barbara Brizz, Hector Bolivar, Mitchell (Mitch) Goldman, David W. Haas, John W. Mellors. Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS. 2009. 23: 1109-18.

Citation

Pablo Tebas, Jiameng Zhang, Richard Hafner, Karen T. Tashima, Abby Helen Shevitz, Kevin E. Yarasheski, Baiba Berzins, Susan Owens, Jodi Lee Forand, Scott Evans, Robert L. Murphy. Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110. Journal of Antimicrobial Chemotherapy. 2009. 63: 998-1005.

Citation

Allan R. Tenorio, Hongyu Jiang, Yu (Evelyn) Zheng, Barbara Bastow, Daniel R. Kuritzkes, John Alexander Bartlett, Steven G. Deeks, Alan Landay, Sharon A. Riddler. Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115. AIDS Research and Human Retroviruses. 2009. 25: 135-9.

Citation

Timothy J. Wilkin, Roy (Trip) Gulick, Athe Tsibris, Daniel R. Kuritzkes, Roger Paredes, Amy Chadburn, Zhaohui Su, Timothy Henrich, Amy Krambrink, Michael Hughes, Judith A. Aberg, Judith Silverstein Currier, Karen T. Tashima, Catherine Godfrey, Wayne Greaves, Charles Flexner, Paul Skolnik. Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS clinical trials group A5211. Clinical Infectious Diseases. 2009. 48: 642-9.

Citation

Charles Flexner, Chad Nusbaum, Athe Tsibris, Daniel R. Kuritzkes, Bette T. Korber, Ramy Arnaout, Carsten Russ, Chien-Chi Lo, Thomas Leitner, Brian Gaschen, James Theiler, Roger Paredes, Zhaohui Su, Michael Hughes, Roy (Trip) Gulick, Wayne Greaves, Eoin Coakley. Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. Public Library of Science One. 2009. 4: e5683 1-12.

Citation

Wei Jiang, Michael M. Lederman, Peter W. Hunt, Scott F. Sieg, Kathryn Haley, Benigno Rodriguez, Alan Landay, Jeffrey N. Martin, Elizabeth Sinclair, John Spritzler, Ava I. Asher, Steven G. Deeks, Daniel C Douek, Jason M. Brenchley. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. Journal of Infectious Diseases. 2009. 199: 1177¿85.

Citation

Zhaohui Su, J. Reeves, Amy Krambrink, Eoin Coakley, Michael Hughes, Cong Han, Charles Flexner, Timothy J. Wilkin, Paul Skolnik, Wayne Greaves, Daniel R. Kuritzkes, Roy (Trip) Gulick. Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211. Journal of Infectious Diseases. 2009. 200: 1724-28.